Cargando…
Update on the Preventive Antibiotics in Stroke Study (PASS): a randomised controlled phase 3 clinical trial
BACKGROUND: Stroke is a leading cause of death worldwide. Infections after stroke occur in 30% of stroke patients and are strongly associated with unfavourable outcome. Preventive antibiotic therapy lowers infection rate in patients after stroke, however, the effect of preventive antibiotic treatmen...
Autores principales: | Westendorp, Willeke F, Vermeij, Jan-Dirk, van Geloven, Nan, Dippel, Diederik WJ, Dijkgraaf, Marcel GW, van der Poll, Tom, Prins, Jan M, Spanjaard, Lodewijk, Vermeij, Frederique H, Nederkoorn, Paul J, van de Beek, Diederik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4000143/ https://www.ncbi.nlm.nih.gov/pubmed/24750904 http://dx.doi.org/10.1186/1745-6215-15-133 |
Ejemplares similares
-
Update of the Preventive Antibiotics in Stroke Study (PASS): statistical analysis plan
por: Westendorp, Willeke F, et al.
Publicado: (2014) -
Post-stroke infection: A systematic review and meta-analysis
por: Westendorp, Willeke F, et al.
Publicado: (2011) -
Development and internal validation of a prediction rule for post-stroke infection and post-stroke pneumonia in acute stroke patients
por: Westendorp, Willeke F, et al.
Publicado: (2018) -
Prevalence, predictors and outcome of carotid stenosis: a sub study in the Preventive Antibiotics in Stroke Study (PASS)
por: van Velzen, Twan J, et al.
Publicado: (2021) -
Preventive ceftriaxone in patients at high risk of stroke-associated pneumonia. A post-hoc analysis of the PASS trial
por: Sluis, Wouter M., et al.
Publicado: (2022)